RT Journal Article
SR Electronic
T1 Cutaneous surgical wounds have distinct microbiomes from intact skin
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.05.22274498
DO 10.1101/2022.05.05.22274498
A1 Gupta, Sameer
A1 Poret, Alexandra J.
A1 Hashemi, David
A1 Eseonu, Amarachi
A1 Yu, Sherry H.
A1 D’Gama, Jonathan
A1 Neel, Victor A.
A1 Lieberman, Tami D.
YR 2022
UL http://medrxiv.org/content/early/2022/09/26/2022.05.05.22274498.abstract
AB Infections are relatively rare following cutaneous surgical procedures, despite the potential for wound exposure to pathogens both during surgery and throughout the healing process. Although gut commensals are believed to reduce the risk of intestinal infections, an analogous role for skin commensals has not been described. In fact, the microbiome of normally healing surgical skin wounds has not yet been profiled using culture-independent techniques. We characterized the wound microbiome in 53 patients who underwent skin cancer surgery and healed without signs or symptoms of infection. A week after surgery, several bacterial species displayed significant differences in relative abundance when compared to control, non-operated skin from the same patient. The most common bacteria found on intact skin, Cutibacterium acnes, was depleted in wounds 5-fold. Staphylococcus aureus, a frequent cause of postoperative skin infections, was enriched 6.4-fold in clinically non-infected wounds, suggesting active suppression of pathogenicity. Finally, members of the Corynebacterium genus were the dominant organism in postoperative wounds, making up 37% of the average wound microbiome. The enrichment of these bacteria in normally healing wounds suggests they might be capable of providing colonization resistance. Future studies focused on the biological and clinical significance of the wound microbiome may shed light on normal wound healing and potential therapeutic opportunities to mitigate infection risk.Importance Commensal bacteria on skin may limit the ability of pathogenic bacteria to cause clinically-significant infections. The bacteria on healing acute wounds, which might provide such a protective effect, have not been described using culture-independent approaches in the absence of antibiotics. We compare the microbiome of wounds a week after skin cancer removal surgery with intact skin from the same patient. We find that the potentially pathogenic species S. aureus is common on these normally healing wounds, despite the absence of symptoms or signs of infection. We report that bacteria often considered as potential skin probiotics, including S. epidermidis, do not reach high abundance in wound microbiomes. In contrast, specific members of the Cornyebacterium genus, rarely associated with skin infections, were enriched in healing wounds relative to intact skin. Future work is needed to see if Corynebacterium species or derivatives thereof could be employed to lower the risk of wound infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a Harvard Catalyst grant (to Victor Neel).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequencing data is available under the BioProject number PRJNA809947. Code and data processing scripts can additionally be found at https://github.com/ajporet/cutaneous_wound_microbiome.